8-HYDROXYWARFARIN

Details

Stereochemistry	RACEMIC
Molecular Formula	C19H16O5
Molecular Weight	324.3273
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(=O)CC(C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C(O)=CC=C3

InChI

InChIKey=BHBOXPNWDGYJNB-UHFFFAOYSA-N

InChI=1S/C19H16O5/c1-11(20)10-14(12-6-3-2-4-7-12)16-17(22)13-8-5-9-15(21)18(13)24-19(16)23/h2-9,14,21-22H,10H2,1H3

HIDE SMILES / InChI

Molecular Formula	C19H16O5
Molecular Weight	324.3273
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Approval Year

PubMed

Title	Date	PubMed

Substance Class	Chemical Created by `admin` on `Sat Dec 16 08:59:50 GMT 2023` Edited by `admin` on `Sat Dec 16 08:59:50 GMT 2023`
Record UNII	T1CK4E3S36
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

8-HYDROXYWARFARIN

Common Name

English

2H-1-BENZOPYRAN-2-ONE, 4,8-DIHYDROXY-3-(3-OXO-1-PHENYLBUTYL)-

Systematic Name

English

8-HYDROXYWARFARIN, (RS)-

Common Name

English

Code System Code Type Description

EPA CompTox

DTXSID70939075

Created by admin on Sat Dec 16 08:59:50 GMT 2023 , Edited by admin on Sat Dec 16 08:59:50 GMT 2023

PRIMARY

FDA UNII

T1CK4E3S36

Created by admin on Sat Dec 16 08:59:50 GMT 2023 , Edited by admin on Sat Dec 16 08:59:50 GMT 2023

PRIMARY

CAS

17834-04-7

Created by admin on Sat Dec 16 08:59:50 GMT 2023 , Edited by admin on Sat Dec 16 08:59:50 GMT 2023

PRIMARY

PUBCHEM

54697550

Created by admin on Sat Dec 16 08:59:50 GMT 2023 , Edited by admin on Sat Dec 16 08:59:50 GMT 2023

PRIMARY

Related Record Type Details


					5Q7ZVV76EI

WARFARIN

PARENT -> METABOLITE INACTIVE

Comments:

metabolism of warfarin include CYP2C9, 2C19, 2C8, 2C18, 1A2, and 3A4. CYP2C9, a polymorphic enzyme, is likely to be the principal form of human liver CYP450 that modulates the in vivo anticoagulant activity of warfarin.